Literature DB >> 20010311

Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline.

Heather B Jaspan1, Adam W Brothers, Angela J P Campbell, John K McGuire, Samuel R Browd, Thomas J Manley, Daniel Pak, Scott J Weissman.   

Abstract

A case of enterococcal meningitis in a toddler is presented. The organism was highly resistant to all drugs previously used for pediatric Gram-positive meningitis. She was successfully treated with intraventricular and intravenous daptomycin and intravenous tigecycline. The organism was characterized as a member of CC17, a notorious emerging nosocomial clone of Enterococcus faecium.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20010311      PMCID： PMC4778705          DOI： 10.1097/INF.0b013e3181c806d8

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  9 in total

1.  Treatment of meningitis due to methicillin-resistant Staphylococcus epidermidis with linezolid.

Authors:  Wolfgang A Krueger; Bernd Kottler; Bernd E Will; Alexandra Heininger; Heinz Guggenberger; Klaus E Unertl
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.

Authors:  Issam I Raad; Hend A Hanna; Ray Y Hachem; Tanya Dvorak; Rebecca B Arbuckle; Gassan Chaiban; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin.

Authors:  Juliet Elvy; David Porter; Erwin Brown
Journal:  J Antimicrob Chemother       Date:  2007-12-21       Impact factor: 5.790

4.  Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.

Authors:  Keith A Rodvold; Mark H Gotfried; Michael Cwik; Joan M Korth-Bradley; Gary Dukart; Evelyn J Ellis-Grosse
Journal:  J Antimicrob Chemother       Date:  2006-09-29       Impact factor: 5.790

5.  Multilocus sequence typing scheme for Enterococcus faecium.

Authors:  Wieger L Homan; David Tribe; Simone Poznanski; Mei Li; Geoff Hogg; Emile Spalburg; Jan D A Van Embden; Rob J L Willems
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.

Authors:  Peter Gerber; Armin Stucki; Fernando Acosta; Marianne Cottagnoud; Philippe Cottagnoud
Journal:  J Antimicrob Chemother       Date:  2006-02-03       Impact factor: 5.790

Review 7.  Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen.

Authors:  Janetta Top; Rob Willems; Marc Bonten
Journal:  FEMS Immunol Med Microbiol       Date:  2008-02-14

8.  Successful treatment of vancomycin-resistant enterococcus ventriculitis in a child.

Authors:  Paulo Sérgio Lucas da Silva; Henrique Monteiro Neto; Lílian Márcia Sejas
Journal:  Braz J Infect Dis       Date:  2007-04       Impact factor: 1.949

9.  Daptomycin therapy for invasive Gram-positive bacterial infections in children.

Authors:  Monica I Ardura; Asunción Mejías; Kathy S Katz; Paula Revell; George H McCracken; Pablo J Sánchez
Journal:  Pediatr Infect Dis J       Date:  2007-12       Impact factor: 2.129
  9 in total
  17 in total

1.  Low tigecycline concentrations in the cerebrospinal fluid of a neutropenic patient with inflamed meninges.

Authors:  Claudia Lengerke; Michael Haap; Frank Mayer; Lothar Kanz; Martina Kinzig; Ulrike Schumacher; Fritz Sörgel; Reimer Riessen
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

2.  The Use of Daptomycin to Treat Methicillin-Resistant Staphylococcus Epidermidis Bacteremia in a Critically Ill Child with Renal Failure.

Authors:  Stephen Morris; Kate Gould; Lee P Ferguson
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jul-Aug

Review 3.  Intrathecal Antibacterial and Antifungal Therapies.

Authors:  Roland Nau; Claudia Blei; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

4.  Multidrug-resistant Acinetobacter baumannii infection in children.

Authors:  Maia De Luca; Giulia Angelino; Francesca Ippolita Calò Carducci; Alessandra Martino; Stefania Bernardi; Paola Bernaschi; Michaela Carletti; Patrizia D'Argenio; Paolo Palma
Journal:  BMJ Case Rep       Date:  2011-08-11

5.  Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.

Authors:  Theodoros Kelesidis; Romney Humphries; Kevin Ward; Michael A Lewinski; Otto O Yang
Journal:  Diagn Microbiol Infect Dis       Date:  2011-08-19       Impact factor: 2.803

Review 6.  Management of multidrug-resistant enterococcal infections.

Authors:  C A Arias; G A Contreras; B E Murray
Journal:  Clin Microbiol Infect       Date:  2010-06       Impact factor: 8.067

7.  Antimicrobial susceptibility among Gram-positive organisms collected from pediatric patients globally between 2004 and 2011: results from the Tigecycline Evaluation and Surveillance Trial.

Authors:  Michael Brandon; Michael J Dowzicky
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

Review 8.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

9.  Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.

Authors:  Jose M Munita; Nagendra N Mishra; Danya Alvarez; Truc T Tran; Lorena Diaz; Diana Panesso; Jinnethe Reyes; Barbara E Murray; Javier A Adachi; Arnold S Bayer; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2014-08-08       Impact factor: 9.079

10.  Preliminary experience with tigecycline treatment for severe infection in children.

Authors:  Sheng Ye; Chenmei Zhang; Shupeng Lin
Journal:  Eur J Pediatr       Date:  2018-07-14       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.